表紙
市場調查報告書

骨關節炎治療藥的全球市場:2020年∼2024年

Global Osteoarthritis Therapeutics Market 2020-2024

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 823140
出版日期 內容資訊 英文 120 Pages
訂單完成後即時交付
價格
骨關節炎治療藥的全球市場:2020年∼2024年 Global Osteoarthritis Therapeutics Market 2020-2024
出版日期: 2020年04月20日內容資訊: 英文 120 Pages
簡介

全球骨關節炎治療藥市場在2020年∼2024年的預測期間內,預計將以9%的年複合成長率增長,達到29億9,185萬美元的規模。市場成長的主要因素有骨關節炎的發病率增加和診斷方法的可用性提高。特別是,骨關節炎的發病率上升有望推動市場增長。

本報告提供全球骨關節炎治療藥市場相關調查分析,提供市場規模及成長率,市場趨勢,推動市場要素,課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

目錄

摘要整理

市場形勢

市場規模

  • 市場定義
  • 市場區隔分析
  • 2019年的市場規模
  • 市場預測:從2019年∼2024年的預測

波特的五力分析

各產品市場區隔

  • 市場區隔
  • 各產品比較:市場規模·預測(2019年∼2024年)
  • 止痛藥·NSAID
  • 皮質類固醇
  • 關節內補充藥
  • 其他
  • 各產品的市場機會

各類型市場區隔

  • 腳關節骨關節炎
  • 變形性髖關節症
  • 變形性膝關節症
  • 肩膀的骨關節炎
  • 其他

客戶形勢

  • 概要

各地區形勢

  • 各地區市場區隔
  • 各地區比較:市場規模·預測(2019年∼2024年)
  • 北美
  • 歐洲
  • 亞洲
  • 其他地區
  • 主要國家
  • 各地區的市場機會

成長要素,課題,及趨勢

  • 市場成長要素
  • 交易量的成長要素-需求主導型成長
  • 市場課題
  • 市場趨勢

業者情勢

  • 業者情勢
  • 形勢的創新

供應商分析

  • 交易廠商
  • Abbott Laboratories
  • Anika Therapeutics Inc.
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • Zimmer Biomet Holdings Inc.

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR43212

Technavio has been monitoring the osteoarthritis therapeutics market and it is poised to grow by $ 2991.85 million during 2020-2024 progressing at a CAGR of 9% during the forecast period. Our reports on osteoarthritis therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing incidence of osteoarthritis and availability of improved diagnostic modalities. In addition, increasing incidence of osteoarthritis is anticipated to boost the growth of the market as well.

The osteoarthritis therapeutics market analysis includes product segment and geographic landscapes

Technavio's ‘ osteoarthritis therapeutics market ’ is segmented as below:

By Product

  • Analgesics and NSAIDs
  • Corticosteriods
  • Viscosupplements
  • Others

By Geographic Landscapes:

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the availability of guidelines for disease management as one of the prime reasons driving the osteoarthritis therapeutics market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our osteoarthritis therapeutics market covers the following areas:

  • Osteoarthritis therapeutics market sizing
  • Osteoarthritis therapeutics market forecast
  • Osteoarthritis therapeutics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading osteoarthritis therapeutics market vendors that include Abbott Laboratories, Anika Therapeutics Inc., Bayer AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson & Johnson, Novartis AG, Pfizer Inc., Sanofi, and Zimmer Biomet Holdings Inc.. Also, the osteoarthritis therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five Force Summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product

  • Market segments
  • Comparison by Product
  • Analgesics and NSAIDs - Market size and forecast 2019-2024
  • Corticosteriods - Market size and forecast 2019-2024
  • Viscosupplements - Market size and forecast 2019-2024
  • Others - Market size and forecast 2019-2024
  • Market opportunity by Product

Market Segmentation by Type

  • Ankle osteoarthritis
  • Hip osteoarthritis
  • Knee osteoarthritis
  • Shoulder osteoarthritis
  • Others

Customer landscape

  • Overview

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Volume driver - Demand led growth
  • Market challenges
  • Market trends

Vendor Landscape

  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Abbott Laboratories
  • Anika Therapeutics Inc.
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • Zimmer Biomet Holdings Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2019 - 2024 ($ million)
  • 13: Global market: Year-over-year growth 2019 - 2024 (%)
  • 14: Five forces analysis 2019 & 2024
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2019
  • 21: Product - Market share 2019-2024 (%)
  • 22: Comparison by Product
  • 23: Analgesics and NSAIDs - Market size and forecast 2019-2024 ($ million)
  • 24: Analgesics and NSAIDs - Year-over-year growth 2019-2024 (%)
  • 25: Corticosteriods - Market size and forecast 2019-2024 ($ million)
  • 26: Corticosteriods - Year-over-year growth 2019-2024 (%)
  • 27: Viscosupplements - Market size and forecast 2019-2024 ($ million)
  • 28: Viscosupplements - Year-over-year growth 2019-2024 (%)
  • 29: Others - Market size and forecast 2019-2024 ($ million)
  • 30: Others - Year-over-year growth 2019-2024 (%)
  • 31: Market opportunity by Product
  • 32: Customer landscape
  • 33: Market share by geography 2019-2024 (%)
  • 34: Geographic comparison
  • 35: North America - Market size and forecast 2019-2024 ($ million)
  • 36: North America - Year-over-year growth 2019-2024 (%)
  • 37: Europe - Market size and forecast 2019-2024 ($ million)
  • 38: Europe - Year-over-year growth 2019-2024 (%)
  • 39: Asia - Market size and forecast 2019-2024 ($ million)
  • 40: Asia - Year-over-year growth 2019-2024 (%)
  • 41: ROW - Market size and forecast 2019-2024 ($ million)
  • 42: ROW - Year-over-year growth 2019-2024 (%)
  • 43: Key leading countries
  • 44: Market opportunity by geography ($ million)
  • 45: Impact of drivers and challenges
  • 46: Vendor landscape
  • 47: Landscape disruption
  • 48: Industry risks
  • 49: Vendors covered
  • 50: Market positioning of vendors
  • 51: Abbott Laboratories - Overview
  • 52: Abbott Laboratories - Business segments
  • 53: Abbott Laboratories - Key offerings
  • 54: Abbott Laboratories - Key customers
  • 55: Abbott Laboratories - Segment focus
  • 56: Anika Therapeutics Inc. - Overview
  • 57: Anika Therapeutics Inc. - Business segments
  • 58: Anika Therapeutics Inc. - Key offerings
  • 59: Anika Therapeutics Inc. - Key customers
  • 60: Anika Therapeutics Inc. - Segment focus
  • 61: Bayer AG - Overview
  • 62: Bayer AG - Business segments
  • 63: Bayer AG - Key offerings
  • 64: Bayer AG - Key customers
  • 65: Bayer AG - Segment focus
  • 66: F. Hoffmann-La Roche Ltd. - Overview
  • 67: F. Hoffmann-La Roche Ltd. - Business segments
  • 68: F. Hoffmann-La Roche Ltd. - Key offerings
  • 69: F. Hoffmann-La Roche Ltd. - Key customers
  • 70: F. Hoffmann-La Roche Ltd. - Segment focus
  • 71: GlaxoSmithKline Plc - Overview
  • 72: GlaxoSmithKline Plc - Business segments
  • 73: GlaxoSmithKline Plc - Key offerings
  • 74: GlaxoSmithKline Plc - Key customers
  • 75: GlaxoSmithKline Plc - Segment focus
  • 76: Johnson & Johnson - Overview
  • 77: Johnson & Johnson - Business segments
  • 78: Johnson & Johnson - Key offerings
  • 79: Johnson & Johnson - Key customers
  • 80: Johnson & Johnson - Segment focus
  • 81: Novartis AG - Overview
  • 82: Novartis AG - Business segments
  • 83: Novartis AG - Key offerings
  • 84: Novartis AG - Key customers
  • 85: Novartis AG - Segment focus
  • 86: Pfizer Inc. - Overview
  • 87: Pfizer Inc. - Business segments
  • 88: Pfizer Inc. - Key offerings
  • 89: Pfizer Inc. - Key customers
  • 90: Pfizer Inc. - Segment focus
  • 91: Sanofi - Overview
  • 92: Sanofi - Business segments
  • 93: Sanofi - Key offerings
  • 94: Sanofi - Key customers
  • 95: Sanofi - Segment focus
  • 96: Zimmer Biomet Holdings Inc. - Overview
  • 97: Zimmer Biomet Holdings Inc. - Business segments
  • 98: Zimmer Biomet Holdings Inc. - Key offerings
  • 99: Zimmer Biomet Holdings Inc. - Key customers
  • 100: Zimmer Biomet Holdings Inc. - Segment focus
  • 101: Currency conversion rates for US$
  • 102: Research Methodology
  • 103: Validation techniques employed for market sizing
  • 104: Information sources
  • 105: List of abbreviations